Archive
Past newsletters of MDDR.
Loading the archive
Past newsletters of MDDR.
Past newsletters of MDDR.
Saturday, 20 June 2026
A call has emerged for a revised Pharmacy Code of Conduct to better align with current community pharmacy practices. The existing code is se
Friday, 19 June 2026
The Department of Health, Disability and Ageing has confirmed that verbal consent for bulk billing will be acceptable for the next 12 months
Thursday, 18 June 2026
A new federal report indicates Australia is producing more medical graduates but is failing to train enough specialists to meet community ne
Wednesday, 17 June 2026
The US Food and Drug Administration (FDA) has approved a new medication specifically for treating agitation associated with dementia due to
Tuesday, 16 June 2026
Victoria has opened expressions of interest for GPs to receive training in diagnosing, treating, and prescribing for ADHD in adults and chil
Monday, 15 June 2026
The Cholesterol Treatment Trialists’ Collaboration conducted a meta-analysis of double-blind randomised controlled trials to evaluate the ca
Sunday, 14 June 2026
The NSW pharmacist-led UTI trial treated over 17,000 women in under a year, demonstrating a structured approach to managing uncomplicated ur
Saturday, 13 June 2026
A Victorian coronial inquest has reignited discussions on the role of GPs in assessing firearm licence applicants. The inquest followed the
Thursday, 11 June 2026
The Therapeutic Goods Administration (TGA) issued a safety update regarding FluMist, the intranasal influenza vaccine, after over 80 childre
Wednesday, 10 June 2026
A report by the Medical Protection Society (MPS) highlights that doctors are increasingly exposed to legal claims due to the evolving use of